BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27653311)

  • 1. A case of occipital neuralgia in a vemurafenib-treated melanoma patient.
    Hoashi T; Matsumoto N; Serizawa N; Kataoka K; Nako T; Shirakawa N; Matano Y; Funasaka Y; Saeki H
    Int J Dermatol; 2017 Jan; 56(1):e10-e11. PubMed ID: 27653311
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitiligo in 2 patients receiving vemurafenib for metastatic melanoma.
    Alonso-Castro L; Ríos-Buceta L; Vano-Galvan S; Moreno C; Soria-Rivas A; Jaén P
    J Am Acad Dermatol; 2013 Jul; 69(1):e28-9. PubMed ID: 23768302
    [No Abstract]   [Full Text] [Related]  

  • 3. Vemurafenib-associated gingival hyperplasia in patient with metastatic melanoma.
    Mangold AR; Bryce A; Sekulic A
    J Am Acad Dermatol; 2014 Nov; 71(5):e205-6. PubMed ID: 25437992
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythema nodosum in a patient undergoing vemurafenib therapy for metastatic melanoma.
    Degen A; Völker B; Kapp A; Gutzmer R
    Eur J Dermatol; 2013; 23(1):118. PubMed ID: 23419281
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple white cysts on face and trunk of a melanoma patient treated with vemurafenib.
    Gebhardt C; Staub J; Schmieder A; Goerdt S; Utikal J
    Acta Derm Venereol; 2015 Jan; 95(1):96-7. PubMed ID: 24710689
    [No Abstract]   [Full Text] [Related]  

  • 6. Vemurafenib sensitivity skin reaction after ipilimumab.
    Harding JJ; Pulitzer M; Chapman PB
    N Engl J Med; 2012 Mar; 366(9):866-8. PubMed ID: 22375995
    [No Abstract]   [Full Text] [Related]  

  • 7. Tinea hidden by a vemurafenib-induced phototoxic reaction in a patient with metastatic melanoma taking dexamethasone.
    Anforth R; Carlos G; Eiris N; Clements A; Fernandez-Peñas P
    Med J Aust; 2015 Jul; 203(1):41-2. PubMed ID: 26126567
    [No Abstract]   [Full Text] [Related]  

  • 8. Vemurafenib (Zelboraf) with longer follow-up. Metastatic melanoma: a few extra months of life, but many adverse effects.
    Prescrire Int; 2015 Apr; 24(159):89-90. PubMed ID: 25941696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual complication of vemurafenib treatment of metastatic melanoma: exacerbation of acantholytic dyskeratosis complicated by Kaposi varicelliform eruption.
    Gupta M; Huang V; Linette G; Cornelius L
    Arch Dermatol; 2012 Aug; 148(8):966-8. PubMed ID: 22911209
    [No Abstract]   [Full Text] [Related]  

  • 10. Vemurafenib-induced granuloma annulare.
    Lee SB; Weide B; Ugurel S; Mössner R; Enk A; Hassel JC
    J Dtsch Dermatol Ges; 2016 Mar; 14(3):305-8. PubMed ID: 26972200
    [No Abstract]   [Full Text] [Related]  

  • 11. Uveitic macular oedema after treatment with vemurafenib.
    Fonollosa A; Mesquida M; Adan A
    Acta Ophthalmol; 2015 Dec; 93(8):e686-7. PubMed ID: 25683228
    [No Abstract]   [Full Text] [Related]  

  • 12. Vemurafenib-induced panniculitis.
    Villani AP; Zaharia D; Dalle S; Depaepe L; Balme B; Thomas L
    Eur J Dermatol; 2013 Apr; 23(2):258-60. PubMed ID: 23567624
    [No Abstract]   [Full Text] [Related]  

  • 13. Fanconi syndrome induced by vemurafenib: a new renal adverse event.
    Denis D; Franck N; Fichel F; Levi C; Dupin N
    JAMA Dermatol; 2015 Apr; 151(4):453-4. PubMed ID: 25494458
    [No Abstract]   [Full Text] [Related]  

  • 14. Vemurafenib-induced eccrine squamous syringometaplasia.
    Lescoat A; Droitcourt C; Stock N; Le Gall F; Dupuy A
    Dermatology; 2013; 226(4):362-4. PubMed ID: 23860306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed oral toxicity from long-term vemurafenib therapy.
    Lloyd-Lavery A; Hodgson T; Coupe N; Bond S; Shah K; Espinosa O; Payne MJ; Middleton MR; Matin RN
    Br J Dermatol; 2016 May; 174(5):1159-60. PubMed ID: 26853702
    [No Abstract]   [Full Text] [Related]  

  • 16. Vemurafenib-induced hypertension: is it real?
    Balakan O; Babacan T; Altundag K
    J BUON; 2013; 18(2):545. PubMed ID: 23818377
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma.
    Anker CJ; Ribas A; Grossmann AH; Chen X; Narra KK; Akerley W; Andtbacka RH; Noyes RD; Shrieve DC; Grossmann KF
    J Clin Oncol; 2013 Jun; 31(17):e283-7. PubMed ID: 23650406
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced expression of the ATP2A2 gene in vemurafenib-induced keratoacanthoma-like papules in a melanoma patient.
    Wakimoto H; Harada K; Arai T; Maeda T; Irisawa R; Tsuboi R
    Int J Dermatol; 2017 Feb; 56(2):e33-e35. PubMed ID: 27805257
    [No Abstract]   [Full Text] [Related]  

  • 19. Efflorescence of scalp cysts during vemurafenib treatment following brain radiation therapy: a radiation recall dermatitis?
    Reigneau M; Granel-Brocard F; Geoffrois L; Bauman AS; Tréchot P; Barbaud A; Schmutz JL
    Eur J Dermatol; 2013; 23(4):544-5. PubMed ID: 24001519
    [No Abstract]   [Full Text] [Related]  

  • 20. RASopathic alopecia: hair changes associated with vemurafenib therapy.
    Piraccini BM; Patrizi A; Fanti PA; Starace M; Bruni F; Melotti B; Misciali C; Dika E
    J Am Acad Dermatol; 2015 Apr; 72(4):738-41. PubMed ID: 25773419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.